Sponsor:
Women's College Hospital
Code:
NCT02225015
Conditions
BRCA1 Gene Mutation
BRCA2 Gene Mutation
Breast Cancer
Ovarian Cancer
Eligibility Criteria
Sex: Female
Age: 35 - 70
Healthy Volunteers: Not accepted
Interventions
Follow-up Telephone Genetic Counselling
Brief summary:
Conditions
BRCA1 Gene Mutation
BRCA2 Gene Mutation
Breast Cancer
Ovarian Cancer
Study ID
NCT02225015
Start date
Jan, 2015
Status verified date
Jun, 2016
Completion date
Jun, 2019
Anticipated
Primary completion date
Jun, 2018
Anticipated
Eligibility Criteria
Sex: Female
Age: 35 - 70
Healthy Volunteers: Not accepted
Enrollment
300 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Supportive Care
Arms
active comparator: FTGC at 1 month
no intervention: Standard Care + FTGC in 12 months
Interventions
Follow-up Telephone Genetic Counselling
Primary outcome measure
Central contacts
Locations
Women's College Hospital
Recruiting
Toronto, Ontario, Canada, M5S 1B1
Contacts
Sponsor
Women's College Hospital
Last update posted
Jun 9, 2016
Last verified
Jun, 2016
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Women's College Hospital on 2016-06-09.